147 related articles for article (PubMed ID: 10826605)
1. Preparation of a new carboranyl lactoside for the treatment of cancer by boron neutron capture therapy: synthesis and toxicity of fluoro carboranyl glycosides for in vivo 19F-NMR spectroscopy.
Tietze LF; Bothe U; Schuberth I
Chemistry; 2000 Mar; 6(5):836-42. PubMed ID: 10826605
[TBL] [Abstract][Full Text] [Related]
2. Novel carboranyl C-glycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Griesbach U; Schuberth I; Bothe U; Marra A; Dondoni A
Chemistry; 2003 Mar; 9(6):1296-302. PubMed ID: 12645018
[TBL] [Abstract][Full Text] [Related]
3. Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Bothe U; Griesbach U; Nakaichi M; Hasegawa T; Nakamura H; Yamamoto Y
Chembiochem; 2001 May; 2(5):326-34. PubMed ID: 11828461
[TBL] [Abstract][Full Text] [Related]
4. Ortho-carboranyl glycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Bothe U; Griesbach U; Nakaichi M; Hasegawa T; Nakamura H; Yamamoto Y
Bioorg Med Chem; 2001 Jul; 9(7):1747-52. PubMed ID: 11425576
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides.
Mourier NS; Eleuteri A; Hurwitz SJ; Tharnish PM; Schinazi RF
Bioorg Med Chem; 1999 Dec; 7(12):2759-66. PubMed ID: 10658581
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of fluorinated p-boronophenylalanine derivatives as a boron carrier.
Hattori Y; Kurihara K; Kondoh H; Asano T; Kirihata M; Yamaguchi Y; Wakamiya T
Protein Pept Lett; 2007; 14(3):269-72. PubMed ID: 17346232
[TBL] [Abstract][Full Text] [Related]
7. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil.
Fulcrand-el Kattan G; Goudgaon NM; Ilksoy N; Huang JT; Watanabe KA; Sommadossi JP; Schinazi RF
J Med Chem; 1994 Aug; 37(16):2583-8. PubMed ID: 8057301
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine.
Schinazi RF; Goudgaon NM; Fulcrand G; el Kattan Y; Lesnikowski Z; Ullas G; Moravek J; Liotta DC
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1113-20. PubMed ID: 8175396
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy.
da Silva AF; Seixas RS; Silva AM; Coimbra J; Fernandes AC; Santos JP; Matos A; Rino J; Santos I; Marques F
Org Biomol Chem; 2014 Jul; 12(28):5201-11. PubMed ID: 24915168
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazole.
Wilbur DS; Hamlin DK; Livesey JC; Srivastava RR; Laramore GE; Griffin TW
Nucl Med Biol; 1994 May; 21(4):601-11. PubMed ID: 9234317
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of functionalized carboranes as potential anticancer and BNCT agents.
Reddy VJ; Roforth MM; Tan C; Reddy MV
Inorg Chem; 2007 Jan; 46(2):381-3. PubMed ID: 17279815
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble carboranyl-phthalocyanines for BNCT. Synthesis, characterization, and in vitro tests of the Zn(II)-nido-carboranyl-hexylthiophthalocyanine.
Pietrangeli D; Rosa A; Pepe A; Altieri S; Bortolussi S; Postuma I; Protti N; Ferrari C; Cansolino L; Clerici AM; Viola E; Donzello MP; Ricciardi G
Dalton Trans; 2015 Jun; 44(24):11021-8. PubMed ID: 25995094
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.
Agarwal HK; Khalil A; Ishita K; Yang W; Nakkula RJ; Wu LC; Ali T; Tiwari R; Byun Y; Barth RF; Tjarks W
Eur J Med Chem; 2015 Jul; 100():197-209. PubMed ID: 26087030
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
17. Tuning the Cell Uptake and Subcellular Distribution in BODIPY-Carboranyl Dyads: An Experimental and Theoretical Study.
Labra-Vázquez P; Flores-Cruz R; Galindo-Hernández A; Cabrera-González J; Guzmán-Cedillo C; Jiménez-Sánchez A; Lacroix PG; Santillan R; Farfán N; Núñez R
Chemistry; 2020 Dec; 26(69):16530-16540. PubMed ID: 32608048
[TBL] [Abstract][Full Text] [Related]
18. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues.
Yan J; Naeslund C; Al-Madhoun AS; Wang J; Ji W; Cosquer GY; Johnsamuel J; Sjöberg S; Eriksson S; Tjarks W
Bioorg Med Chem Lett; 2002 Aug; 12(16):2209-12. PubMed ID: 12127539
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
Cai J; Hosmane NS; Takagaki M; Zhu Y
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
